Author
Executive Director and Managing Trustee, Blossom Trust India
The intellectual property rights of global pharma majors can pose a threat to the pharma industry’s patient-centric approach. A substantial number of Indians live in poverty which is why the country puts a premium on public health vis-à-vis pharmaceutical patent law decisions
Read More
